Prognostic value of the systemic immune-inflammation index, systemic inflammation response index, and prognostic nutritional index in head and neck cancer

[1]  M. Tsai,et al.  Systemic Immun e–Inflammation Index as a Predictor for Head and Neck Cancer Prognosis: A Meta-Analysis , 2022, Frontiers in Oncology.

[2]  P. Boscolo-Rizzo,et al.  Different inflammatory blood markers correlate with specific outcomes in incident HPV-negative head and neck squamous cell carcinoma: a retrospective cohort study , 2022, BMC cancer.

[3]  D. Solter,et al.  Systemic Inflammatory Markers as Predictors of Postoperative Complications and Survival in Patients With Advanced Head and Neck Squamous Cell Carcinoma Undergoing Free-Flap Reconstruction. , 2021, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[4]  Büşra Yılmaz,et al.  Pretreatment Systemic Immune-Inflammation Index Predict Needs for Teeth Extractions for Locally Advanced Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy , 2021, Therapeutics and clinical risk management.

[5]  P. Chiovati,et al.  Prognostic Nutritional Index Predicts Toxicity in Head and Neck Cancer Patients Treated with Definitive Radiotherapy in Association with Chemotherapy , 2021, Nutrients.

[6]  Hsin-Yi Yang,et al.  Prognostic Value of C-Reactive Protein-to-Albumin Ratio in Head and Neck Cancer: A Meta-Analysis , 2021, Diagnostics.

[7]  Xiaohua Hu,et al.  Prognostic value of systemic inflammatory marker in patients with head and neck squamous cell carcinoma undergoing surgical resection. , 2020, Future oncology.

[8]  M. Quer,et al.  Prognostic capacity of Systemic Inflammation Response Index (SIRI) in patients with head and neck squamous cell carcinoma , 2019, Head & neck.

[9]  P. Saintigny,et al.  mTOR Signalling in Head and Neck Cancer: Heads Up , 2019, Cells.

[10]  P. Costantino,et al.  Neutrophil‐to‐lymphocyte ratio as a prognostic indicator in head and neck cancer: A systematic review and meta‐analysis , 2018, Head & neck.

[11]  F. Papaccio,et al.  Prognostic Nutritional Index as an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer , 2018, ESMO Open.

[12]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[13]  Wan-Hai Wang,et al.  Prognostic value of Systemic immune-inflammation index in cancer: A meta-analysis , 2018, Journal of Cancer.

[14]  Wendong Gu,et al.  Development and validation of nomogram based on SIRI for predicting the clinical outcome in patients with nasopharyngeal carcinomas , 2018, Journal of Investigative Medicine.

[15]  P. Costantino,et al.  The lymphocyte-to-monocyte ratio as a prognostic indicator in head and neck cancer: a systematic review and meta-analysis , 2018, European Archives of Oto-Rhino-Laryngology.

[16]  Mark Bangert,et al.  Design and Selection of Machine Learning Methods Using Radiomics and Dosiomics for Normal Tissue Complication Probability Modeling of Xerostomia , 2018, Front. Oncol..

[17]  H. Muramatsu,et al.  Immunological Status May Predict Response to Nivolumab in Non-small Cell Lung Cancer without Driver Mutations. , 2017, Anticancer research.

[18]  Xuesong Li,et al.  Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival with Bladder Cancer after Radical Cystectomy: a retrospective study , 2017, BMC Cancer.

[19]  I. El Naqa,et al.  Beyond imaging: The promise of radiomics. , 2017, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[20]  A. D. Dei Tos,et al.  Prognostic significance of LINE-1 hypomethylation in oropharyngeal squamous cell carcinoma , 2017, Clinical Epigenetics.

[21]  B. O'Sullivan,et al.  Overview of the 8th Edition TNM Classification for Head and Neck Cancer , 2017, Current Treatment Options in Oncology.

[22]  Liang Zhou,et al.  The prognostic value of preoperative neutrophils, platelets, lymphocytes, monocytes and calculated ratios in patients with laryngeal squamous cell cancer , 2017, Oncotarget.

[23]  Zhen Chen,et al.  A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy , 2016, Cancer.

[24]  S. Grossman,et al.  Association between severe treatment‐related lymphopenia and progression‐free survival in patients with newly diagnosed squamous cell head and neck cancer , 2014, Head & neck.

[25]  S. Clarke,et al.  Cancer-related inflammation and treatment effectiveness. , 2014, The Lancet. Oncology.

[26]  Ben Tran,et al.  Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. , 2014, Journal of the National Cancer Institute.

[27]  Yun-Fei Xia,et al.  Influence of pretreatment ideal body weight percentile and albumin on prognosis of nasopharyngeal carcinoma: Long‐term outcomes of 512 patients from a single institution , 2014, Head & neck.

[28]  J. Moreno,et al.  Protein Malnutrition Impairs the Immune Response and Influences the Severity of Infection in a Hamster Model of Chronic Visceral Leishmaniasis , 2014, PloS one.

[29]  D. McMillan.  The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. , 2013, Cancer treatment reviews.

[30]  Shahid A. Khan,et al.  A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI). , 2012, Journal of hepatology.

[31]  D. Gupta,et al.  Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature , 2010, Nutrition journal.

[32]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[33]  J. Blay,et al.  Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. , 2009, Cancer research.

[34]  A. Argiris,et al.  Prognostic factors and long‐term survivorship in patients with recurrent or metastatic carcinoma of the head and neck , 2004, Cancer.

[35]  C. Fisher,et al.  Tumour thickness predicts cervical nodal metastases and survival in early oral tongue cancer. , 2003, Oral oncology.

[36]  K. Sugimachi,et al.  Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma. , 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[37]  E. McFadden,et al.  Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.